Chairman of the Board
Revance is a biotechnology pioneer establishing a new category of long-lasting neuromodulators. By fusing cutting-edge science with the entrepreneurial spirit of Silicon Valley, we are daring to make a difference by introducing aesthetic and therapeutic treatments that meaningfully transform patient experiences.
We believe in leaving bureaucracy behind. We value speed, audacity, grit and empathy, and empower our teams to reimagine the status quo.
DaxiboutlinumtoxinA for Injection (DAXI) is the first, long-lasting neuromodulator. DAXI is the first and only new formulation of a neuromodulator with the inclusion of a proprietary peptide.Learn More
Our board brings together exceptional executives in science, healthcare, and business who dare to make a difference.
Daring to Make a Difference
Revance’s leadership is committed to disrupting the status quo and has deep experience commercializing products in highly competitive markets. As a group, we represent more than a century of experience launching innovative products that change people’s lives.
We are dedicated to making a difference by transforming patient experiences. We believe in leaving bureaucracy behind. We value speed, audacity, grit and empathy, and empower our teams to reimagine the status quo.
Co-Founder, President & CEO of Revance, Inc.
Chief Operating Officer
Chief Financial Officer
Senior Vice President, General Counsel & Corporate Secretary
Head of Commercial, Aesthetics and Therapeutics
Vice President, Human Resources and Head of People